Anthony Kong

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Hisham Mehanna, Max Robinson, A. Hartley et al. · The Lancet · 2018 · 988 citations · Full text

Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer

Alexandra Canonici, Merel Gijsen, Maeve Mullooly et al. · Oncotarget · 2013 · 162 citations · Full text

Trastuzumab Resistance, Breast Oncology, Trastuzumab-sensitive Breast Cancer +13

Salivary Gland Toxicity after Radioiodine Therapy for Thyroid Cancer

Stephen Hyer, Anthony Kong, B. Pratt et al. · Clinical Oncology · 2006 · 131 citations

Medicine, Thyroid Disease, Thyroid Cancer +7

HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer

Merel Gijsen, Peter King, Tim Perera et al. · PLoS Biology · 2010 · 128 citations · Full text

Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study

Kevin J. Harrington, Anthony Kong, Nicolas Mach et al. · Clinical Cancer Research · 2020 · 104 citations